A role for neuronal NF-κB in suppressing neuroinflammation and promoting neuroprotection in the CNS

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 575-581

  Emmanouil, Mary ^a   Taoufik, Era ^a   Tseveleki, Vivian ^a   Vamvakas, Sotiris Spyros ^a   Probert, Lesley ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN; CHEMOKINE; I KAPPA B KINASE; NEUROPROTECTIVE AGENT;

ALLERGIC ENCEPHALOMYELITIS; CELL ACTIVATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEMYELINATION; DISEASE ACTIVITY; GENE EXPRESSION; GENE TARGETING; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPATIAL MEMORY; SYNAPTIC TRANSMISSION; ANIMAL; ARTICLE; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PATHOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GENE TARGETING; HUMANS; I-KAPPA B KINASE; INFLAMMATION; MICE; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B;

EID: 79954448463     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_60     Document Type: Conference Paper

References (20)

1. Wekerle H (1993) Experimental autoimmune encephalomyelitis as a model of immunemediated CNS disease. Curr Opin Neurobiol 3(5):779-784
2. Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(8):1953-1971
3. DeAngelis T, Lublin F (2008) Neurotherapeutics in multiple sclerosis: Novel agents and emerging treatment strategies. Mt Sinai J Med 75(2):157-167
4. Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y (1999) Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: Roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 163(5):2937-2943
5. Greve B, Weissert R, Hamdi N, Bettelli E, Sobel RA, Coyle A, Kuchroo VK, Rajewsky K, Schmidt-Supprian M (2007) I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis. J Immunol 179(1):179-185
6. van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinzi MR, PasparakisM(2006) Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat Immunol 7:954-961
7. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR (2009) Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 182:2628-2640
8. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA (2001) Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7(12):1291-1297
9. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D (2003) NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6(10):1072-1078
10. Albensi BC, Mattson MP (2000) Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35(2):151-159
11. Kaltschmidt B, Ndiaye D, Korte M, Pothion S, Arbibe L, Prullage M, Pfeiffer J, Lindecke A, Staiger V, Israel A, Kaltschmidt C, Memet S (2006) NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol 26(8):2936-2946
12. Youssef S, Steinman L (2006) At once harmful and beneficial: The dual properties of NF-kappaB. Nat Immunol 7(9):901-902
13. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(2):S81-S96
14. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3(3): 221-227
15. Park JM, Greten FR, Li ZW, Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297(5589):2048-2051
16. Li ZW, Omori SA, Labuda T, Karin M, Rickert RC (2003) IKK beta is required for peripheral B cell survival and proliferation. J Immunol 170(9):4630-4637
17. Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24(2):401-414
18. Emmanouil M, Taoufik E, Tseveleki V, Vamvakas SS, Tselios T, Karin M, Lassmann H, Probert L (2009) Neuronal I?B Kinase β protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the CNS. J Immunol 183:7877-7889
19. Taoufik E, Valable S, Muller GJ, Roberts ML, Divoux D, Tinel A, Voulgari-Kokota A, Tseveleki V, Altruda F, Lassmann H, Petit E, Probert L (2007) FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 27(25):6633-6646
20. Kreuz S, Siegmund D, Scheurich P, Wajant H (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21:3964-3973